Global Aphakia Market to Show Strong Growth | Valeant ZEISS International Rayner, Bohus BioTech AB Lifecore Biomedical Aetna Inc. The Cooper Companies Inc. Menicon Co., Ltd. Labtician Ophthalmics, Inc. Artificial Eye Co.

Global Aphakia Market

A market research study of this Aphakia report help businesses in gaining knowledge about what is already there in the market, what market looks forward to, the competitive background and steps to take up to outshine the rivals. This market report leads to systematic problem analysis, model building and fact-finding for the purpose of decision-making and control in the marketing of goods and services. This Aphakia market report searches and analyses data which are relevant to marketing problems. By completely understanding client’s requirements and following them strictly, this Aphakia market research report has been structured.

Global Aphakia Market is expected to register a substantial CAGR of 9.9% in the forecast period of 2019-2026. The Aphakia  market is amplifying in the forecast years of 2019-2026 and pulling the  industry with it.The condition in which there is absence or dislocation of the crystalline eye lens from its normal position of pupillary area is termed as “Aphakia”. Largely responsible due to the existence of trauma and congenital conditions or after surgery for cataract removal. Some of the factors such as rising prevalence of diseases such as diabetes & trauma and growing number of accident have contributed to the growth of the aphakia market. Global Aphakia Market By Types (Primary, Secondary), Cause (Congenital Aphakia, Surgical Aphakia, Acquired Aphakia), Treatment (Spectacles, Contact Lenses, Intraocular Lens Implantation, Refractive Surgery), End Users (Hospitals, Ophthalmic Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026 – Industry Trends & Forecast to 2026.

(SPECIAL OFFER (Avail Up-to 25% discount on this report)

Request Research Sample Pages:

Aphakia market report provides complete information about manufacturers, suppliers, distributors, traders, customers, investors and major types as well as applications. Aphakia Market is segmented based on type, application, and region. Global market report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in Aphakia industry with analysis on vendors, geographical regions, types, applications. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure and so on.

According to Journal of Acute Disease, trauma is considered as one of the major health problems worldwide which causes about 10% of the deaths and induces 5.1 million deaths per year. Out of all the deaths 90% of trauma deaths occurred in the low- and middle-income countries.

Also, according National Center for Biotechnology Information, in 2017, around 451 million people suffered with diabetes globally.

Market Drivers and Restraints:

  • Increasing demand for treatment of the ophthalmic diseases.
  • Rapid development in healthcare sector.
  • Increased geriatric population.
  • Expensive surgeries.
  • Less treatment availability hampers the market.

The major players in the market are as follows:

  • Johnson & Johnson Services, Inc.
  • Ophtec BV
  • Novartis
  • Valeant
  • ZEISS International
  • Rayner, Bohus BioTech AB
  • Lifecore Biomedical
  • Aetna Inc.
  • The Cooper Companies Inc.
  • Menicon Co., Ltd.
  • Labtician Ophthalmics, Inc.
  • Artificial Eye Co.
  • Contact Fill
  • MJS Lens Technology Ltd.
  • Alsanza Medizintechnik und Pharma GmbH.
  • Abbott and UltraVision CLPL

Get TOC For Full Analysis Of Report:

Competitive Analysis: Global Aphakia Market

The global aphakia market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global aphakia market for global, Europe, North America, Asia Pacific and South America.

Key Developments in the Market:

  • In January 2017, CooperVision, Inc. announced the commencement of its limited rollout of Avaira Vitality toric which is the latest technological advancement in the two-week contact lens and addition to the new Avaira Vitality family. This new lens is made up of silicone hydrogel material (fanfilcon A) which helps it to deliver best of Avaira toric having a higher water content of 55) along with high level of oxygen permeability and transmissibility. All these advantages results in an improved lens-wearing experience. It also provides UV protection which means these lenses can now block more than 90% of UVA and 99% of UVB rays. All these developments are accessible at the same reasonable price point as Avaira toric.

Features of the Report

  1. Key trends in the market place
  2. Major players and brands
  3. Drivers and restrains of the market
  4. Key developments in the market
  5. Challenges of market growth

Want Full Report? Enquire Here:

Reasons to Purchase this Report

  • Current and future of global aphakia market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost
Report Rating